Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Perseus Mining Ltd. PMNXF


Primary Symbol: T.PRU

Metals & Mining Gold
Perseus Mining Limited is an Australia-based gold producer, developer, and explorer. The Company also conducts mineral exploration and evaluation activities in Africa. It operates three gold mines in Africa: Edikan in Ghana and Sissingue and Yaoure in Cote d’Ivoire and owns the Meyas Sand Gold Project in Sudan. Edikan Gold Mine is a large-scale, low-grade multi open-pit operation located in the... see more

Showcase News Releases

Showcase news

Lithium Ionic Corp
Lithium Ionic Expands Newly Discovered Zone at Salinas; Drills 1.53% Li2O over 15m, incl. 2.31% Li2O over 8m; 1.15% Li2O over 19m, incl. 1.67% Li2O over 10m, and 1.32% Li2O over 14m
Revive Therapeutics Ltd.
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
G Mining Ventures Corp.
G Mining Ventures Completes Second and Final Draw on $75 Million Term Loan from Franco-Nevada

More Showcase News Releases »